000 | 01165 a2200313 4500 | ||
---|---|---|---|
005 | 20250517093131.0 | ||
264 | 0 | _c20180101 | |
008 | 201801s 0 0 eng d | ||
022 | _a1879-0852 | ||
024 | 7 |
_a10.1016/j.ejca.2016.03.065 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Jong, Roy G P J | |
245 | 0 | 0 |
_aComments on "Use of metformin and risk of kidney cancerĀ in patients with type 2 diabetes", Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25. _h[electronic resource] |
260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c07 2016 |
||
300 |
_a157-8 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aDiabetes Mellitus, Type 2 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHypoglycemic Agents |
650 | 0 | 4 | _aKidney Neoplasms |
650 | 0 | 4 | _aMetformin |
650 | 0 | 4 | _aRisk |
700 | 1 | _aNielen, Johannes T H | |
700 | 1 | _aMasclee, Ad A M | |
700 | 1 | _aJanssen-Heijnen, Maryska L G | |
700 | 1 | _ade Vries, Frank | |
773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 61 _gp. 157-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2016.03.065 _zAvailable from publisher's website |
999 |
_c25974761 _d25974761 |